Iovance Biotherapeutics, Inc. (IOVA) stock
IOVANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3087% above fair value
$7.48−0.05 (-0.66%)
Close on Nov 18, 2026Market cap $3.39BP/E –Yield –
Iovance Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Iovance Biotherapeutics's market cap was $3.66B on Nov 11, 2026, against $952.09M a year earlier. Over the last 5 years it ranged from $574.37M to $6.71B, with a median of $1.69B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.66B | +248.2% |
| 2025 | Dec 31, 2025 | $1.05B | -53.3% |
| 2024 | Dec 31, 2024 | $2.25B | +8.4% |
| 2023 | Dec 29, 2023 | $2.08B | +106.2% |
| 2022 | Dec 30, 2022 | $1.01B | -66.3% |
| 2021 | Dec 31, 2021 | $2.99B | -56.0% |
| 2020 | Dec 31, 2020 | $6.80B | +94.7% |
| 2019 | Dec 31, 2019 | $3.49B | +305.1% |
| 2018 | Dec 31, 2018 | $862.22M | +49.8% |
| 2017 | Dec 29, 2017 | $575.64M | +33.7% |
| 2016 | Dec 30, 2016 | $430.54M | +16.7% |
| 2015 | Dec 31, 2015 | $369.07M | +69.7% |
| 2014 | Dec 31, 2014 | $217.52M | +37.4% |
| 2013 | Dec 31, 2013 | $158.27M | +818.8% |
| 2012 | Dec 31, 2012 | $17.22M | -76.6% |
| 2011 | Dec 30, 2011 | $73.64M | – |
See a number that looks wrong?